Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 14NETWORK 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Brain Neoplasms 5Squamous Cell Carcinoma of Head and Neck 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Gliosarcoma 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma 2Breast Neoplasms 2Urogenital Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Rare Diseases 1Pancreatic Neoplasms 1Oligodendroglioma 1Meningioma 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1Genetic Diseases, Inborn 1Carcinoma, Renal Cell 1Carcinoma, Merkel Cell 1

Interventions

Radiotherapy 26Cisplatin 17Fluorouracil 13Paclitaxel 10Carboplatin 6Chemotherapy, Adjuvant 5Cetuximab 5Immunohistochemistry 4Docetaxel 4Radiotherapy, Intensity-Modulated 3Immunoenzyme Techniques 3Hydroxyurea 3Gemcitabine 3Gefitinib 3Filgrastim 3Bortezomib 3sargramostim 2bintrafusp alfa protein, human 2aldesleukin 2Tetrahydrouridine 2SS1(dsFv)PE38 2Radiotherapy, Conformal 2Polymerase Chain Reaction 2Oxaliplatin 2Neoadjuvant Therapy 2Methotrexate 2Magnetic Resonance Spectroscopy 2Leucovorin 2Gene Expression Profiling 2Fluorodeoxyglucose F18 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Head and Neck Neoplasms × Radiosurgery × Clear all
NCT00738868 2011-05-13

Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

National Cancer Institute (NCI)

Phase 2 Completed
45 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡